Ashland’s $3.3-billion deal to acquire Hercules gives the company its long-sought “specialty core,” says Ashland chairman and CEO James O’Brien. Hercules, with 2007 revenues of $2.1 billion, has leading positions in cellulose esters...
This information is only available to Chemical Week 24/7 members and subscribers.
Forgot your user ID or password? Click here to have it sent to you.
Not a Chemical Week
24/7 member yet? Here's why you
should be: Searchable online archive
access of the last 2 years
of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers